Home › Funds › Artia Global Partners LP › IONS
Artia Global Partners LP position in IONS
IONIS PHARMACEUTICALS INC · Health Care
Artia Global Partners LP reported holding 144,376 shares of IONS (IONIS PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$11.4M, representing 2.11% of its reported portfolio and ranking #14 among its reported holdings. Artia Global Partners LP has disclosed IONS holdings in 6 of the last 9 reported quarters, going back to Q2 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Artia Global Partners LP's IONS position evolved
Artia Global Partners LP first disclosed a stake in IONS in Q2 2024 at 62,479 shares (US$3.0M). The position peaked in Q2 2026 at 144,376 shares, worth US$11.4M. Across 6 filings, Artia Global Partners LP increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 144,376 shares valued at US$11.4M. Notable position changes include a 51% trim in Q3 2024 (shares fell 13% over the following quarter), a 140% increase in Q4 2025 (shares fell 5% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 62.48K | $2.98M | New |
| Q3 2024 | 30.48K | $1.22M | Reduce |
| Q3 2025 | 60.18K | $3.94M | New |
| Q4 2025 | 144.38K | $11.42M | Add |
| Q1 2026 | 144.38K | $10.84M | Hold |
| Q2 2026 | 144.38K | $11.45M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IONS and 13F data
IONS (IONIS PHARMACEUTICALS INC) is a Health Care company. 42 other funds we track also report a position in IONS — the largest reported positions include Two Sigma Investments (US$495.7M), TWO SIGMA ADVISERS, LP (US$241.5M), Tweedy, Browne Co LLC (US$180.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IONS
- Two Sigma Investments 6.25M sh · $495.75M · Q2 2026
- TWO SIGMA ADVISERS, LP 3.05M sh · $241.45M · Q4 2025
- Tweedy, Browne Co LLC 2.28M sh · $180.81M · Q2 2026
- Deep Track Capital, LP 2.20M sh · $174.44M · Q2 2026
- BAKER BROS. ADVISORS LP 2.05M sh · $162.36M · Q2 2026
- TENOR CAPITAL MANAGEMENT Co., L.P. 94.68M sh · $147.77M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 60.00M sh · $93.10M · Q2 2026
- Bellevue Group AG 972.26K sh · $77.09M · Q2 2026
- GROUPAMA ASSET MANAGMENT 937.08K sh · $75.20M · Q2 2026
- Davern Capital Partners, LP 798.71K sh · $63.33M · Q2 2026
- SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 787.26K sh · $62.42M · Q2 2026
- Eversept Partners, LP 664.68K sh · $52.70M · Q2 2026
More on Artia Global Partners LP
FAQ
How long has Artia Global Partners LP held IONS?
Artia Global Partners LP has disclosed IONS holdings in 6 of the last 9 reported quarters, going back to Q2 2024.
What is Artia Global Partners LP's current position in IONS?
As of Q2 2026, Artia Global Partners LP holds 144.38K shares of IONS (IONIS PHARMACEUTICALS INC), valued at $11.45M, representing 2.11% of its reported portfolio and ranking #14.
Has Artia Global Partners LP been buying or selling IONS?
In the latest 13F filing (Q2 2026), Artia Global Partners LP held unchanged its position in IONS. The position peaked in Q2 2026 at 144.38K shares.
Which other funds hold IONS?
Other major institutional holders of IONS include Two Sigma Investments, TWO SIGMA ADVISERS, LP, Tweedy, Browne Co LLC, among 42 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.